SoftOx Solutions

SoftOx Solutions AS is a clinical-stage pharmaceutical company based in Oslo, Norway, listed on Euronext Growth Oslo under the ticker 'SOFTX'. The company has developed a non-toxic and highly efficient antimicrobial technology designed to address major health challenges, including airway infections, antimicrobial resistance (AMR), VAP and chronic infections, and the spread of viruses. Its SoftOx Inhalation Solution (SIS) is described as effective against pathogens causing VAP and other airway infections/pneumonia, and as having a strong virucidal capacity. The company was founded in 2012 and is headquartered in Oslo. The SoftOx Solutions Group includes the holding company SoftOx Solutions AS, the Malmö subsidiary Water Innovation AS, and subsidiaries SoftOx Defense Solutions AS.

SoftOx Solutions AS was founded in 2012 and is headquartered in Oslo. It is a pharmaceutical company listed on Euronext Growth Oslo under the ticker 'SOFTX'. The SoftOx Solutions Group includes the holding company SoftOx Solutions AS, the Malmö subsidiary Water Innovation AS, and subsidiaries SoftOx Defense Solutions AS. SoftOx is developing a highly effective antimicrobial solution for biofilm, viral, and antimicrobial-resistant infections, based on patent-protected technology developed through extensive research and development in partnership with leading Nordic research institutes. The company has raised a total of NOK 383 million, of which NOK 50 million was raised before its IPO. After the IPO, SoftOx completed several private placements: on 21/12/2018 raising NOK 15 million through 680,000 new shares at NOK 22 each; on 12/12/2019 raising approximately NOK 75 million through 3,125,000 new shares at NOK 24 per share; on 16/12/2020 raising approximately NOK 50 million through 909,090 new shares at NOK 55 per share in two tranches; and on 15/12/2021 raising approximately NOK 50 million through 915,000 new shares.

Clinical-stage pharmaceutical company developing a non-toxic, highly efficient antimicrobial technology.

• SoftOx Inhalation Solution (SIS)

  Effective against pathogens causing VAP as well as other airway infections/pneumonia, with a strong virucidal capacity.

1. 1Home - SoftOx Solutionssoft-ox.com
2. 2Company Info - SoftOx Solutionssoft-ox.com
3. 3SoftOx Solutions (Norway)wikidata.org